📣In a prospective nationwide Danish cohort of adults with #VZV #encephalitis: - fever was present at admission in only 39% - early receipt (<6h) of #acyclovir did not reduce mortality or significantly improve other outcomes at 6 months #IDSky #clinmicro #virosky www.cmi-comms.org/article/S295...

Time to acyclovir and outcome of varicella zoster virus encephalitis: A prospective population-based cohort study

Varicella zoster virus (VZV) is a leading cause of encephalitis. This study aimed to examine associations between timing of acyclovir and outcome of patients with VZV encephalitis.

cmi-comms.org

📣 In a prospective nationwide Danish cohort of adults with #VZV #encephalitis: - fever was present at admission in only 39% - early receipt (<6h) of #acyclovir did not reduce mortality or significantly improve other outcomes at 6 months #IDSky #virosky #virosky www.cmi-comms.org/article/S295...

Time to acyclovir and outcome of varicella zoster virus encephalitis: A prospective population-based cohort study

Varicella zoster virus (VZV) is a leading cause of encephalitis. This study aimed to examine associations between timing of acyclovir and outcome of patients with VZV encephalitis.

cmi-comms.org

🎙️ Just published Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain Hosted by Nav Narayanan & Thomas Tängdén with invited guests, Sören Gatermann, Christian Giske & Amy Mathers 🌟 Listen on #Communicable: https://share.transistor.fm/s/e2e4ad7e #IDSky #clinmicro

Communicable | Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain

share.transistor.fm

🎙️ Just published Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain Hosted by Nav Narayanan & Thomas Tängdén with invited guests, Sören Gatermann, Christian Giske & Amy Mathers 🌟 Listen on #Communicable: https://share.transistor.fm/s/e2e4ad7e #IDSky #clinmicro

Communicable | Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explain

share.transistor.fm

📣 Q fever poses diagnostic and management challenges. This multinational position paper systematically assesses various countries' responses to #Qfever outbreaks and provides recommendations for future management. #IDSky #clinmicro #episky #Coxiella #zoonosis https://ow.ly/HeQx50ZsckH

Super interesting - great to see more examples that #microbiome imbalances have consequences beyond their immediate niches #UTISky #UTI

CMI Communications@cmicomms.bsky.social · 2w ago

📣 New evidence that #UTI & bacterial vaginosis exist on a continuum of dysbiosis. In this metagenomic study of >600 adults, women with UTI symptoms were nearly 3x more likely to have Nugent #BV. #Lactobacillus crispatus is a protector. #IDSky #UTISky #MicroSky www.cmi-comms.org/article/S295...

So proud of our @cmicomms.bsky.social editorial fellow Victor Dahl for his gorgeous essay in @thelancetinfdis.bsky.social The Optimism in Front of Us. #IDSky #clinmicro @hoferu.bsky.social www.thelancet.com/journals/lan...

The optimism in front of us

The world often feels dark when seen through today's headlines. Conflict, division, mistrust, and crisis compete for attention.1 However, working and training in infectious diseases offers a different...

thelancet.com

📣 New evidence that #UTI & bacterial vaginosis exist on a continuum of dysbiosis. In this metagenomic study of >600 adults, women with UTI symptoms were nearly 3x more likely to have Nugent #BV. #Lactobacillus crispatus is a protector. #IDSky #UTISky #MicroSky www.cmi-comms.org/article/S295...

Vaginal dysbiosis is associated with urinary symptoms and urinary tract infection: A case–control study

Limited data suggest that bacterial vaginosis (BV) and the composition of the vaginal microbiome may be associated with urinary symptoms and urinary tract infection (UTI). We investigated these relati...

cmi-comms.org

📣New #Communicable drops Mon 27 July! Kicking off our new 'Ask me anything' series, hosts Nav Narayanan & Thomas Tängdén invite EUCAST & CLSI leadership – Sören Gatermann, Christian Giske & Amy Mathers – to answer your questions on setting breakpoints, clarifying common misconceptions, and more! 🎙️

🔬 S. aureus bacteremia therapy webinar 📅 25 Aug 2026 • 13:00 CEST Hear new evidence from DOTS, early oral switch studies & the SNAP trial, plus key unanswered questions in SAB management us02web.zoom.us/webinar/regi... @heiman-wertheim.bsky.social @souhakanj.bsky.social @esgni-escmid.bsky.social

📣 The Dutch multidisciplinary guideline on community-acquired #pneumonia is out. Rational, GRADE-based recommendations for the diagnosis & treatment of #CAP requiring hospitalisation. (Sputum cultures & procalcitonin discouraged.) #IDSky #clinmicro www.cmi-comms.org/article/S295...

Management of community-acquired pneumonia in adults: Practice Guideline from The Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians

This guideline is meant for the diagnosis and antibiotic treatment of adult patients without an immunocompromising condition with community-acquired pneumonia (CAP) who present at the hospital.

cmi-comms.org

Infection prevention and control #IPC might not be sexy, but prevention is better than a cure. Therefore those Drs that prevent disease are saving lives, even if it doesn't appear to be very "glamorous" #IDEpi #MedSky

CMI Communications@cmicomms.bsky.social · 3w ago

🎙️ Just published Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened Hosted by Angela Huttner & Josh Davis w/ guests Prof Brett Mitchell, Aline Wolfensberger & Lauren Clack #IDSky #clinmicro Listen on #Communicable: https://share.transistor.fm/s/825e18f4

🎙️ Just published Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happened Hosted by Angela Huttner & Josh Davis w/ guests Prof Brett Mitchell, Aline Wolfensberger & Lauren Clack #IDSky #clinmicro Listen on #Communicable: https://share.transistor.fm/s/825e18f4

📣New #Communicable drops Mon 13 July! Angela Huttner & Josh Davis are joined by Prof Brett Mitchell, Aline Wolfensberger & Lauren Clack to discuss the HAPPEN trial, a multicentre RCT showing impressive reductions in hospital-acquired #pneumonia, and the studies that led to it.🎙️ #IDSky #clinmicro

🎙️ Just published Communicable E57: We will make you love PK/PD, part 2 – quantitative methods Hosted by Thomas Tängdén and Rekha Pai with invited guests Iris Minichimayr (Austria) & Philip Selby (Australia) 🌟 Listen on #Communicable: https://share.transistor.fm/s/5edacc5d

🚀We're excited to share our latest Antimicrobial Viewpoint, developed collaboratively with @cmicomms.bsky.social. In 'From fixed courses to flexible care', the authors explore why antifungal treatment durations and routes deserve rethinking. 🔗Read the Viewpoint: revive.gardp.org/from-fixed-c...

From fixed courses to flexible care - reconsidering antifungal treatment duration and route - by Ilana Reinhold, Rosanne Sprute, Jannik Stemler & Oliver A. Cornely

The views and opinions expressed in this article are solely those of the original author(s) and do not necessarily represent those of GARDP, their donors and partners, or other collaborators and contr...

revive.gardp.org

📣 New #Communicable drops Monday, 29 June! 'We Will Make You Love PK/PD' series returns with part 2! Thomas Tängdén and Rekha Pai are joined by Iris Minichmayr and Philip Selby to discuss pharmacometrics, PK/PD modelling, and how these quantitative tools can support clinical decision-making. 🎙️

📣 Hughes et al perform molecular typing & whole-genome sequencing of #Staph aureus in patients with severe infections. #MSSA CC152 may be a new/under-recognized lineage in Europe causing #PVL positive necrotizing pneumonia & fasciitis. #IDSky #clinmicro #MedSky www.cmi-comms.org/article/S295...

Severe infections in the Netherlands caused by community-acquired methicillin-susceptible Staphylococcus aureus clonal complex 152 carrying PVL, edinB and etE2

To describe severe community-acquired methicillin-susceptible Staphylococcus aureus (MSSA) clonal complex (CC) 152 infections identified in the Netherlands.

cmi-comms.org

🎙️ Just published Communicable E56: Frequentist vs Bayesian for clinical trial analysis – 99% probability you’ll want to listen to this Hosted by Emily McDonald & Josh Davis with invited guests Roger Lewis & Ian Marschner 🌟 Listen on #Communicable: https://share.transistor.fm/s/7ea020d2 #IDSky

📣 If you have questions about fosfomycin, we have answers! Excellent review article by Tiffany Wu, Kalpana Gupta, @erinmccreary.bsky.social, Sarah Turbett & Jacob Lazarus on oral #fosfomycin & how to use it. #IDSky #clinmicro #UTISky #Medsky #Pharmsky www.cmi-comms.org/article/S295...

📣 New #Communicable drops Monday, 15 June! Join hosts Josh Davis & Emily McDonald with guests Roger Lewis & Ian Marschner as they demystify Bayesian and frequentist statistical approaches in clinical trials, exploring key differences, common misconceptions, and surprising similarities. 🎙️ #IDSky

🎙️ Just published Communicable E55: Bonus episode – Bundibugyo Ebolavirus outbreak Hosted by Angela Huttner and Anne-Grete Märtson with invited guests Daniel Bausch and Martin Grobusch 🌟 Listen on #Communicable: https://share.transistor.fm/s/8750e095

🎙️ A special bonus episode of #Communicable is coming Monday Angela Huttner & Anne-Grete Märtson talk with Daniel Bausch & Martin Grobusch on how #Bundibugyo ebolavirus differs from Zaire & what to expect in the current outbreak #IDSky #Virosky #clinmicro https://ow.ly/nm5250Z7ViE

🎙️ Just published Communicable E54: ESCMID Global Late Breakers, part 2 Hosted by our editors - Erin McCreary, PharmD, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner 🌟 Listen on #Communicable: https://share.transistor.fm/s/a8cc04bb #ESCMIDGlobal2026 #IDSky #clinmicro

📣 Note to microbiologists & clinicians who need to isolate #Bordetella spp for antibiogram profiling: Klugherz et al. show that adding #vancomycin to #Regan-Lowe agar doubles the rate of isolation in culture #microsky #clinmicro #idsky #pertussis www.cmi-comms.org/article/S295...

Improving Bordetella pertussis isolation from PCR-positive samples: impact of modified Regan-Lowe agar, sample Ct value and transport time on culture positivity

Pertussis diagnosis relies mainly on PCR tests because of their higher sensitivity and faster results than culture methods. This led to a shortage of clinical isolates for resistance testing and genom...

cmi-comms.org

A growing focus of my work is PK/PD in infectious diseases and antimicrobial development. @sidpharm.bsky.social Breakpoints @cmicomms.bsky.social Communicable E51 discusses this 🎙️Sootify link here: open.spotify.com/episode/64ZI... #PKPD #Pharmacokinetics #DrugDevelopment #Pharmacology

Communicable E51: We will make you love PK/PD, part 1

open.spotify.com

🗞️ Person behind the name: Wolbachia are intracellular Gram-negative bacteria that can manipulate their arthropod hosts' reproduction. Discovered by Hertig and Burt Wollbach, Hertig formally named them after his colleague in 1936. #IDSky #clinmicro #microsky www.cmi-comms.org/article/S295...

“The specimen is never wrong”: the pathologist behind Wolbachia

The genus Wolbachia comprises obligate intracellular, Gram-negative bacteria within the order Rickettsiales and the class Alphaproteobacteria, closely related to Ehrlichia, Anaplasma, and Neorickettsi...

cmi-comms.org

🎙️ Just published Communicable E53: ESCMID Global Late Breakers, part 1 Hosted by our editors - Erin McCreary, PharmD, Josh Davis, Marc Bonten, Anne-Grete Märtson , Angela Huttner 🌟 Listen on #Communicable: https://share.transistor.fm/s/e2f3e270 #IDSky #clinmicro #ESCMIDGlobal2026

📣 New #Communicable drops Mon, 18 May! Our editors - Erin McCreary, PharmD, Josh Davis, Marc Bonten, Anne-Grete Märtson, Angela Huttner - discuss some of the Late Breaker trials that caught their attention at #ESCMIDGlobal2026, and whether results will change their practice🎙️ #IDSky #clinmicro

📣 Migrants & refugees face a higher burden of #AMR but lower access to #healthcare & appropriate #antibiotic use, both difficult to quantify An international expert team has created AdMiRE, a WHO-aligned tool to assess & compare across #migrant populations #IDSky www.cmi-comms.org/article/S295...

AdMiRE study: Development and validation of a WHO-aligned tool to assess healthcare access and antibiotic use among migrant populations in Europe—a multicountry Delphi and psychometric study on behalf...

Antimicrobial resistance (AMR) is a growing global health crisis, threatening medical progress and driving increases in morbidity, mortality, and healthcare costs worldwide [1]. The overuse and misuse...

cmi-comms.org